It is 9:54 PM and Maria, a solo LCSW in Oakland, is staring at a letter from Optum giving her ten business days to justify why her client deserves to keep coming to therapy. Session 24 of weekly treatment, real progress, real remaining symptoms, one badly written prior authorization letter away from a coverage cliff. The prior authorization letter for continued outpatient therapy is the highest-leverage piece of administrative writing in a behavioral health practice: it converts your clinical record into the payer's language of medical necessity, and it is exactly the structured, evidence-anchored document AI drafts well, provided you supply the data AI cannot invent. By the end of this lesson you will assemble a continued-authorization request built on a PHQ-9 trajectory, documented functional impairment, and a rationale that survives Optum and UnitedHealthcare concurrent review, with every AI-drafted sentence verified against your own chart.

Why Continued Authorization Is Where Coverage Dies

Initial authorization for outpatient psychotherapy is usually easy; most commercial plans, including UnitedHealthcare through Optum Behavioral Health, no longer require it for routine outpatient sessions at the front end. The pressure point has moved downstream, to concurrent review and continued authorization. Somewhere between session 12 and session 30, depending on the plan and its utilization management algorithm, a reviewer asks the question every payer asks: is continued treatment medically necessary, or has this become supportive maintenance the plan does not have to cover?

That question has a formal structure, and the letter is your answer to it. Medical necessity in behavioral health requires four things, and reviewers look for all four: a covered DSM-5-TR diagnosis with current, active symptoms; functional impairment attributable to those symptoms; treatment following a recognized standard of care; and a reasonable expectation of improvement, demonstrated by measurable progress and specific remaining goals. A letter that establishes three of the four still gets denied. A letter that asserts all four without evidence gets denied too, just more politely.

Here is the framing that governs this lesson: the prior authorization letter is a legal brief, not a clinical narrative. A brief argues from evidence to a conclusion the reader is empowered to grant. Your reviewer cannot grant "this client is doing important work on attachment"; your reviewer can grant "this client meets the plan's medical necessity criteria for continued outpatient psychotherapy." Every sentence either supplies evidence for one of the four elements or gets cut. AI is a strong brief-writer and a terrible witness: it can structure the argument; it cannot supply the facts. That division of labor is the entire method.

The Four Elements Reviewers Actually Check

Walk through the four elements as an Optum reviewer would, because each must be findable in under thirty seconds. First, diagnosis and active symptoms. "Major depressive disorder, recurrent, moderate (F33.1)" is the start, not the finish. The reviewer wants current symptoms: what the client reports now, at session 24, that maps to DSM-5-TR criteria. "Continues to endorse depressed mood most days, early-morning awakening three nights per week, and passive suicidal ideation without plan or intent, most recently denied May 19" shows the disorder is still active. A letter listing only the intake presentation reads as if the client recovered months ago and you forgot to discharge them.

Second, functional impairment: the element clinicians under-document most and reviewers weight most heavily, because impairment distinguishes a treatable disorder from ordinary distress. Be concrete and domain-specific: occupational (a formal performance improvement plan in February, since closed; concentration lapses requiring twice the usual time on complex tasks), social (withdrawal from a weekly soccer league, partially resumed in April), self-care or family role functioning. Trajectory matters: impairment that has improved but not resolved is the textbook justification for continued care.

Third, standard of care. Name the modality and tie it to the diagnosis: "Treatment consists of weekly individual CBT targeting depressive cognitions and behavioral activation, consistent with APA clinical practice guidelines for major depressive disorder." If you have added a specific protocol element (a behavioral activation schedule, a CBT-I module), say so. Reviewers deny "supportive therapy" for moderate depression far more readily than protocol-consistent CBT, because "supportive" reads as maintenance.

Fourth, expectation of improvement, where measurement-based care earns its keep. A PHQ-9 trajectory (intake 19, then 16, 13, 11) shows a disorder responding to treatment that has not yet reached remission. That curve is the most persuasive object in the letter: it proves the treatment works and proves it is not finished. No reviewer can plausibly characterize a 19-to-11 trajectory with residual symptoms as "maintenance."

The PHQ-9 trajectory is the one paragraph in the letter only you can write. AI can format the curve; it cannot know the numbers, and a hallucinated score in a payer submission is a false claim with your signature on it.

What AI Drafts and What Only You Can Supply

The division of labor is strict. AI drafts structure, transitions, payer-facing framing, standard-of-care language, and the formal request paragraph. You supply, from the chart only: the exact diagnosis and ICD-10 code; every assessment score with its administration date; the specific functional impairments and their current status; the modality actually delivered in session (not the modality you generally practice, the one in the notes); session count and frequency; current risk status and the date last assessed; and the number of sessions requested with the planned review point.

This is the payer rule that runs through every lesson in this chapter: every payer document contains verifiable details AI cannot supply, and those details are precisely what the reviewer checks. If your letter says "weekly CBT" and your claims show biweekly sessions for two months, the letter has impeached itself. If your letter cites a PHQ-9 of 11 and a later records request shows no PHQ-9 after session 16, you have a documentation integrity problem worse than a denial. AI tools, including general-purpose models and EHR-integrated assistants like the drafting features in SimplePractice or TherapyNotes AI, will fabricate plausible scores if you let them draft from a vague summary. Never let the model draft from memory of the case. Draft from a structured fact sheet you prepare first.

The fact sheet method is the core skill of this lesson. Before any prompt, open the chart and extract: diagnosis line, score table with dates, impairment notes (quote your own progress notes), modality as documented, risk status with date, session count, and the request. Hand the model the fact sheet and the structure, and instruct it to use nothing outside the sheet. If the practice has a HIPAA-compliant deployment with a BAA, you may include identifiers; with a consumer-grade tool, the fact sheet goes in de-identified and identifiers are merged in afterward, inside the EHR. That is not a stylistic preference; it is the HIPAA line.

Matching the Payer's Template, Not Yours

Optum, like most managed behavioral health organizations, does not want a beautiful letter. It wants its own form, completed precisely, with a clinical attachment in the reviewer's checklist order. Before drafting, pull the payer's current outpatient treatment request form or continued-stay review template from the provider portal; templates change, and submitting last year's form is a common cause of administrative (non-clinical) denial. Map your fact sheet onto the payer's fields first; the narrative letter ties the fields together, it does not substitute for them.

Structure the clinical attachment in the reviewer's order: (1) identifying information, diagnosis, dates of treatment; (2) current symptoms and risk status; (3) functional impairment, current versus baseline; (4) treatment provided, modality, frequency, and measured response with the full score trajectory; (5) remaining goals in measurable terms; (6) the specific request: sessions, frequency, CPT code (90834 or 90837, and if 90837, expect the time-in-session scrutiny the next lesson covers), and the proposed re-review point. A reviewer who can check every box without hunting approves faster and escalates less.

One more payer reality most webinars skip: parity. Under the Mental Health Parity and Addiction Equity Act (MHPAEA), a plan's non-quantitative treatment limitations (NQTLs), and concurrent review is an NQTL, cannot be applied more stringently to behavioral health than to comparable medical-surgical benefits. The 2026 federal posture is complicated: the Departments of Labor, HHS, and Treasury signaled non-enforcement of significant portions of the September 2024 MHPAEA final rule on NQTLs (a May 2025 non-enforcement statement, then a March 2026 court filing indicating they will propose replacement regulations rather than defend the 2024 rule). But statutory parity rights and the CAA 2021 NQTL comparative-analysis requirement persist, and state parity laws (California's SB 855, New York's Timothy's Law, the Illinois parity statute) remain fully enforceable and often exceed the federal floor. You do not lead with parity in a routine request; you hold it in reserve. One sentence, "I request that any adverse determination include the specific medical necessity criteria applied, consistent with the plan's parity obligations," signals that a denial will be contested by someone who knows the escalation path. Lesson four builds the full appeal; here, you are planting the flag.

The Worked Example: The Session 24 Letter, Paragraph by Paragraph

Take Maria's case. Client: 34-year-old, MDD recurrent moderate (F33.1), weekly therapy since November, now at session 24, UnitedHealthcare commercial plan managed by Optum. Fact sheet: PHQ-9 intake 19 (Nov 4), 16 (Jan 6), 13 (Mar 3), 11 (May 12). GAD-7 intake 12, most recent 8. Modality in the notes: CBT with behavioral activation; CBT-I module added in February. Impairment: performance improvement plan at work (Feb, resolved Apr), ongoing concentration complaints, partial social re-engagement. Risk: passive SI without plan or intent through January, denied at every session since March 10, last assessed May 19. Request: 12 weekly 90834 sessions, re-review at session 36.

Now the letter skeleton, with AI-draftable scaffolding in plain text and clinician-only insertions in brackets. Opening: "I am writing to request continued authorization for outpatient individual psychotherapy for [client name, ID, DOB], whom I have treated weekly since [date], currently at session [24], under diagnosis [F33.1, major depressive disorder, recurrent, moderate]." Current status: "The client continues to meet DSM-5-TR criteria, endorsing [depressed mood most days, early-morning awakening three nights weekly, diminished concentration]. Suicidal ideation, present passively at intake, has been denied at every session since [March 10], most recently assessed [May 19]." Response: "Treatment response is documented through measurement-based care: PHQ-9 [19 on Nov 4; 16 on Jan 6; 13 on Mar 3; 11 on May 12], a clinically significant response not yet at remission. GAD-7 has improved from [12] to [8]." Impairment: "Functional gains are partial: a workplace performance improvement plan initiated in [February] resolved in [April], but concentration deficits persist and social re-engagement remains partial." Plan and request: "Continued weekly CBT with behavioral activation and a CBT-I component, consistent with APA practice guidelines for MDD, targets [remission, PHQ-9 below 5; consolidation of occupational functioning; return to baseline social engagement]. I request authorization for [12] additional weekly sessions billed as [90834], with re-review at session [36] or upon remission threshold, whichever is earlier." Closing reserve clause: "Should this request receive an adverse determination, I request the specific medical necessity criteria applied and the credentials of the reviewing clinician, consistent with the plan's obligations under applicable mental health parity law."

Notice what the skeleton does. Every bracket is a fact only the chart can supply; every unbracketed sentence is structure AI drafts in seconds. The letter runs about 400 words, which is correct: reviewers approve concise letters that hit all four elements and skim long ones. And the request is bounded (12 sessions, named re-review trigger), making approval the reviewer's low-friction option.

The Verification Pass Before Submission

The AI draft is a draft until it survives a line-by-line audit against the chart: your signature on a payer submission is an attestation, and a materially false statement in a claim-supporting document is the raw material of fraud allegations, recoupment demands, and board complaints. The verification checklist has seven items. One: every score, with its date, matches the chart exactly; open the assessment record, do not trust memory. Two: the diagnosis and ICD-10 code match the current treatment plan and the codes on submitted claims. Three: the modality named matches what the progress notes actually document; if your notes say "supportive counseling" for ten straight sessions, fix that before describing the treatment as protocol CBT to a payer. Four: session count and frequency match the claims history. Five: the risk statement matches the most recent documented risk assessment, by date; never let a model generalize "no current SI" from an old note. Six: no symptom, quote, or event appears in the letter that is not in the record. Seven: read it aloud once; AI drafts in a confident register, and confidence is exactly where hallucinated specifics hide.

Two failure modes recur in real audits. The first is the smoothing hallucination: the model converts "PHQ-9 scores of 19, 16, 13, 11" into "steady week-over-week improvement," a claim your every-eight-weeks measurement schedule does not support. The second is template bleed: a model that has drafted ten of these letters starts importing phrases from other clients ("the client's recent divorce") into this client's letter. The fact sheet with an explicit "use nothing outside this sheet" instruction reduces both; only the chart-comparison pass eliminates them.

Timing also matters. Concurrent review requests typically carry a five-to-fourteen business day response window depending on plan and state, and a lapsed authorization means sessions delivered in the gap may be denied outright. Build the letter at session 20, not session 24. The fact sheet takes fifteen minutes; the AI draft takes two; the verification pass takes ten. Under half an hour for a document protecting months of clinically necessary treatment, against the two to three hours the same letter takes cold at 9:54 PM.

When the Answer Is No Anyway

Even a perfect letter sometimes draws a denial, because utilization management is a volume business and some denials are issued in the statistical expectation that providers will not appeal. Do not absorb it silently. Your immediate rights are concrete: a written denial must state the specific criteria not met, and you may request a peer-to-peer review with a clinician of comparable specialty, usually within five to ten business days (check the denial letter). In the peer-to-peer, the PHQ-9 trajectory and the bounded request are again your strongest assets; reviewers reverse denials in peer-to-peers more often than clinicians expect, particularly when documentation is measurement-anchored.

Beyond peer-to-peer sit the formal internal appeal, external independent review, and the state escalation path: the Department of Managed Health Care (DMHC) for most California commercial plans, the Department of Financial Services (DFS) in New York, the Texas Department of Insurance (TDI) in Texas. California's SB 855 is especially strong, requiring plans to use nonprofit specialty-association criteria for medical necessity rather than internally developed criteria. Lesson four builds the complete appeal; for now, the point is architectural: today's letter is the evidentiary foundation of any later appeal. A letter built on dated scores, documented impairment, and a named modality converts directly into appeal exhibits; a letter built on adjectives converts into nothing. And one professional note: writing persuasively to a payer is not gaming the system. The medical necessity framework is the system, and a client whose legitimate need is denied because their clinician documented it badly has been failed twice. Making the chart speak the payer's language, with AI handling the formatting and you guarding every fact, is advocacy.

The Applied Problem: The Session 24 Continued-Authorization Packet

Your artifact is the Session 24 Continued-Authorization Packet: a reusable fact-sheet template plus the AI prompt that turns it into a submission-ready letter. Build it on a realistic case around session 20 to 24. Step one: create the fact sheet with eight labeled fields: Diagnosis/ICD-10; Score trajectory (instrument, score, date, minimum three points); Current symptoms (from the two most recent notes); Functional impairment, baseline versus current; Modality as documented; Risk status with date last assessed; Session count and frequency from claims; Request (sessions, frequency, CPT code, re-review trigger). Fill it only from the chart. If any field is thin, that is a documentation finding worth more than the letter: fix the chart practice first.

Step two: run the prompt, adapted to your tool: "You are drafting a continued outpatient authorization request for a managed behavioral health reviewer. Using ONLY the facts in the sheet below, draft a letter under 450 words organized as: diagnosis and treatment dates; current symptoms and risk status; functional impairment with trajectory; modality and measured response with all scores and dates; remaining measurable goals; specific bounded request with re-review point; a closing sentence requesting that any adverse determination state the criteria applied. Do not add, infer, or estimate any clinical fact not in the sheet. Mark any gap with [MISSING] rather than filling it." The [MISSING] instruction is the most important line: it converts hallucination pressure into a visible flag.

Step three: the verification pass. Print the draft and the chart side by side and run the seven-item checklist, initialing each item. Replace any [MISSING] flag with chart data or remove the claim. Map the verified letter onto the payer's current portal form, attach it as the clinical narrative, and calendar the payer's decision deadline plus your next re-review build at session 32. Done looks like this: a letter under 450 words, every number traceable to a dated chart entry, the four medical-necessity elements each findable in one glance, a bounded request, and a parity reserve clause, submitted at least three weeks before the current authorization lapses. Keep the template and prompt in your forms folder; the second letter takes fifteen minutes.

Key Takeaways

• The prior authorization letter for continued therapy is a legal brief arguing four elements: active DSM-5-TR diagnosis, functional impairment, standard-of-care treatment, and expectation of improvement. A letter missing any one gets denied, however clinically rich the rest is.
• The dated PHQ-9 trajectory (19 to 16 to 13 to 11) is the most persuasive object in the letter: it proves treatment works and is not finished. It is also the verifiable detail AI cannot supply; every score comes from the chart, never from the model.
• Draft from a structured fact sheet, never from memory of the case. Instruct the model to use nothing outside the sheet and to mark gaps as [MISSING], converting hallucination pressure into visible flags instead of confident fabrications.
• Match the payer's current template and the reviewer's checklist order. Optum and UnitedHealthcare reviewers approve letters where each element is findable in thirty seconds; an outdated form or buried evidence produces administrative denials.
• Make the request bounded and self-limiting: a specific session count, frequency, CPT code, and a named re-review trigger. Bounded requests make approval the reviewer's low-friction option.
• MHPAEA parity in 2026 requires care: the federal Departments signaled non-enforcement of much of the 2024 NQTL final rule, but statutory parity rights and the CAA 2021 comparative-analysis requirement persist, and state laws like CA SB 855 and NY Timothy's Law remain enforceable. Plant a parity reserve clause; escalate via DMHC (CA), DFS (NY), or TDI (TX).
• Verify before signing: every score, date, code, modality, and risk statement checked against the chart line by line. Your signature on a payer submission is an attestation; the verification pass makes AI-assisted payer writing defensible rather than dangerous.